The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31.

Anti-C1q antibodies are highly prevalent among patients with IgG4-RD, particularly those with renal and skin manifestations.

Worried about breakouts? Here, dermatologists and a cosmetic chemist break down what you need to know about comedogenicity—or ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...

T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.

Ad hoc announcement pursuant to Art. 53 LR This approval from the European Commission is based on robust results from the phase III OLYMPIA and ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...

Real Housewives star Teddi Mellencamp, 43, has been diagnosed with multiple brain tumors potentially linked to a prior ...

From diagnosis to treatment, a speaker at the Masters of Pediatric Dermatology conference discussed updates for treating vascular birth marks in infants.In an interview with Healio, Mercedes E.

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent.

High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to ...

Pigmented Lesion Treatment MarketThe pigmented lesion treatment market is set to expand from USD 3,591.3 million in 2023 to USD 7,614.7 million by 2033, growing at a CAGR of 7.8% over the forecast ...